BlackRock Health Sciences Opportunities Portfolio (BME)
NYSE
45.90
-0.23 (-0.50%)
Closed
Aug 24, 2026
Day's Range
45.6546.26
52 wk Range
35.9546.38
Financial Statements - BME - BlackRock Health Sciences Opportunities Portfolio
Revenue
77.53M▲ 222.1%
Net Income
76.96M▲ 228.2%Net Margin 99.3%
Free Cash Flow
54.58M▼ 16.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 77.53M | 24.07M | 20.41M | -25.97M | 59.66M | 80.09M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 76.96M | 23.45M | 20.01M | -26.47M | 59.11M | 79.56M |
| Income Tax | - | - | - | - | - | - |
| Net Income | 76.96M | 23.45M | 20.01M | -26.47M | 59.11M | 79.56M |
| EPS Basic | - | 1.63 | 1.44 | -2.1 | 4.74 | 6.87 |
| EPS Diluted | - | 1.63 | 1.44 | -2.1 | 4.74 | 6.87 |
| Basic Shares Outstanding | - | 14.38M | 13.90M | 12.60M | 12.47M | 11.58M |
| Diluted Shares Outstanding | - | 14.38M | 13.90M | 12.60M | 12.47M | 11.58M |
| Ebit | - | - | - | - | - | - |
| Ebitda | - | - | - | - | - | - |
| Net Income Continuous Operations | 76.96M | 23.45M | 20.01M | -26.47M | 59.11M | 79.56M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
